Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 5,060.00
+205.00 (4.22%)
At close: Jul 17, 2025, 3:30 PM KST
Kukje Pharma Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 160,433 | 156,463 | 135,373 | 126,583 | 119,746 | 130,395 | Upgrade |
Other Revenue | -0 | -0 | -0 | -0 | -0 | - | Upgrade |
| 160,433 | 156,463 | 135,373 | 126,583 | 119,746 | 130,395 | Upgrade | |
Revenue Growth (YoY) | 14.19% | 15.58% | 6.94% | 5.71% | -8.17% | 17.34% | Upgrade |
Cost of Revenue | 75,634 | 73,968 | 68,148 | 63,329 | 65,275 | 65,590 | Upgrade |
Gross Profit | 84,800 | 82,495 | 67,225 | 63,254 | 54,470 | 64,805 | Upgrade |
Selling, General & Admin | 76,113 | 72,895 | 66,699 | 56,119 | 53,538 | 49,234 | Upgrade |
Research & Development | 2,095 | 1,811 | 2,646 | 1,967 | 2,772 | 3,037 | Upgrade |
Operating Expenses | 79,191 | 75,793 | 69,214 | 57,982 | 56,146 | 58,763 | Upgrade |
Operating Income | 5,608 | 6,702 | -1,989 | 5,273 | -1,676 | 6,041 | Upgrade |
Interest Expense | -1,094 | -1,206 | -1,440 | -1,000 | -696.43 | -650.13 | Upgrade |
Interest & Investment Income | 404.5 | 428.67 | 394.02 | 230.88 | 114.3 | 139.41 | Upgrade |
Earnings From Equity Investments | - | - | - | 23.21 | -72.91 | -13.43 | Upgrade |
Currency Exchange Gain (Loss) | 226.25 | 303.91 | 163.51 | 450.12 | 589.96 | -688.75 | Upgrade |
Other Non Operating Income (Expenses) | 371.72 | 492.72 | -2,254 | 270.73 | 627.72 | 340.29 | Upgrade |
EBT Excluding Unusual Items | 5,516 | 6,721 | -5,126 | 5,247 | -1,113 | 5,169 | Upgrade |
Gain (Loss) on Sale of Investments | 1.1 | 0.59 | 22.11 | - | - | 26.38 | Upgrade |
Gain (Loss) on Sale of Assets | 90.9 | 114.27 | 290.39 | 13.93 | 31.51 | 366.75 | Upgrade |
Asset Writedown | -224.84 | -226.64 | -1,867 | -515.82 | -28.5 | 31.68 | Upgrade |
Pretax Income | 5,384 | 6,609 | -6,681 | 4,745 | -1,110 | 5,594 | Upgrade |
Income Tax Expense | 1,074 | 1,403 | 1,734 | 1,202 | 445.53 | 3,399 | Upgrade |
Earnings From Continuing Operations | 4,310 | 5,206 | -8,415 | 3,543 | -1,556 | 2,195 | Upgrade |
Minority Interest in Earnings | -0 | -0.9 | -0.3 | 14.56 | -3.34 | 8.43 | Upgrade |
Net Income | 4,310 | 5,205 | -8,415 | 3,557 | -1,559 | 2,203 | Upgrade |
Net Income to Common | 4,310 | 5,205 | -8,415 | 3,557 | -1,559 | 2,203 | Upgrade |
Shares Outstanding (Basic) | 20 | 20 | 20 | 20 | 20 | 20 | Upgrade |
Shares Outstanding (Diluted) | 20 | 20 | 20 | 20 | 20 | 20 | Upgrade |
Shares Change (YoY) | 0.28% | 0.53% | -0.03% | -0.03% | -0.03% | -0.00% | Upgrade |
EPS (Basic) | 211.66 | 255.64 | -415.49 | 175.58 | -76.93 | 108.67 | Upgrade |
EPS (Diluted) | 211.66 | 255.64 | -415.49 | 175.58 | -77.14 | 108.67 | Upgrade |
Free Cash Flow | 182.03 | 1,029 | 2,529 | 5,245 | 7,705 | -6,500 | Upgrade |
Free Cash Flow Per Share | 8.94 | 50.53 | 124.88 | 258.88 | 380.18 | -320.63 | Upgrade |
Dividend Per Share | 30.000 | 30.000 | - | - | - | - | Upgrade |
Gross Margin | 52.86% | 52.73% | 49.66% | 49.97% | 45.49% | 49.70% | Upgrade |
Operating Margin | 3.50% | 4.28% | -1.47% | 4.17% | -1.40% | 4.63% | Upgrade |
Profit Margin | 2.69% | 3.33% | -6.22% | 2.81% | -1.30% | 1.69% | Upgrade |
Free Cash Flow Margin | 0.11% | 0.66% | 1.87% | 4.14% | 6.43% | -4.98% | Upgrade |
EBITDA | 8,786 | 9,904 | 2,215 | 9,760 | 2,743 | 9,667 | Upgrade |
EBITDA Margin | 5.48% | 6.33% | 1.64% | 7.71% | 2.29% | 7.41% | Upgrade |
D&A For EBITDA | 3,178 | 3,203 | 4,204 | 4,488 | 4,419 | 3,626 | Upgrade |
EBIT | 5,608 | 6,702 | -1,989 | 5,273 | -1,676 | 6,041 | Upgrade |
EBIT Margin | 3.50% | 4.28% | -1.47% | 4.17% | -1.40% | 4.63% | Upgrade |
Effective Tax Rate | 19.94% | 21.23% | - | 25.34% | - | 60.77% | Upgrade |
Advertising Expenses | - | 3,692 | 6,015 | 7,504 | 7,250 | 6,300 | Upgrade |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.